ACOR Crosses Above Average Analyst Target
September 20, 2017 at 10:25 AM EDT
In recent trading, shares of Acorda Therapeutics Inc (ACOR) have crossed above the average analyst 12-month target price of $23.29, changing hands for $23.35/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..